Co-existence of chronic renal failure, renal clear cell carcinoma, and Blau syndrome

[1]  V. Yang,et al.  The role of inflammation in the pathogenesis of colorectal cancer , 2009, Current colorectal cancer reports.

[2]  L. Punzi,et al.  Clinical and genetic aspects of Blau syndrome: a 25-year follow-up of one family and a literature review. , 2009, Autoimmunity reviews.

[3]  G. Chrousos,et al.  Inverse association of leptin levels with renal cell carcinoma: Results from a case-control study , 2009, Hormones.

[4]  C. Rosé,et al.  Interstitial pneumonitis in Blau syndrome with documented mutation in CARD15. , 2007, Arthritis and rheumatism.

[5]  A. Labanaris,et al.  Renal cell carcinoma in children under 10 years old: a presentation of four cases , 2007, Pediatric Surgery International.

[6]  C. Acar,et al.  Cyclooxygenase-2 expression: Does it have a probable role in tumorigenesis mechanisms of renal cell carcinoma? , 2007, International Urology and Nephrology.

[7]  A. Pappo,et al.  Pediatric renal cell carcinoma: clinical, pathologic, and molecular abnormalities associated with the members of the mit transcription factor family. , 2006, American journal of clinical pathology.

[8]  P. Doyle,et al.  Results from a Case-Control Study of Risk Factors for Congenital Heart Defects in Saudi Arabian Infants , 2006 .

[9]  Thomas Lengauer,et al.  A new CARD15 mutation in Blau syndrome , 2005, European Journal of Human Genetics.

[10]  Mario Albrecht,et al.  Genetics of Crohn disease, an archetypal inflammatory barrier disease , 2005, Nature Reviews Genetics.

[11]  J. Poulik,et al.  Pediatric Renal Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions and Clinicopathologic Associations , 2005, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[12]  J. Rosenbaum,et al.  Blau syndrome mutation of CARD15/NOD2 in sporadic early onset granulomatous arthritis. , 2005, The Journal of rheumatology.

[13]  M. Chamaillard,et al.  Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition , 2004, The EMBO journal.

[14]  G. Elgart,et al.  Blau syndrome: a new kindred. , 2003 .

[15]  M. Chamaillard,et al.  Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection* , 2003, The Journal of Biological Chemistry.

[16]  Xiaoju Wang,et al.  CARD15 mutations in familial granulomatosis syndromes: a study of the original Blau syndrome kindred and other families with large-vessel arteritis and cranial neuropathy. , 2002, Arthritis and rheumatism.

[17]  G. Thomas,et al.  CARD15 mutations in Blau syndrome , 2001, Nature Genetics.

[18]  Judy H. Cho,et al.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease , 2001, Nature.

[19]  J. Ziegler,et al.  Familial granulomatous arthritis (Blau syndrome) with granulomatous renal lesions. , 1998, The Journal of pediatrics.

[20]  L. Ala‐Kokko,et al.  Genetic linkage of familial granulomatous inflammatory arthritis, skin rash, and uveitis to chromosome 16. , 1996, American journal of human genetics.

[21]  Saini Sk,et al.  Liver involvement in familial granulomatous arthritis (Blau syndrome). , 1996 .

[22]  C. Rosé,et al.  Liver involvement in familial granulomatous arthritis (Blau syndrome). , 1996, The Journal of rheumatology.

[23]  V. Michels,et al.  Autosomal dominant granulomatous arthritis, uveitis, skin rash, and synovial cysts. , 1990, The Journal of pediatrics.

[24]  E. Blau.  Familial granulomatous arthritis, iritis, and rash. , 1985, The Journal of pediatrics.